Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Andy Karabajakian; Thibaut Garrivier; Carole Crozes; Nicolas Gadot; Jean Yves Blay; F. Bérard; Philippe Céruse; Philippe Zrounba; Pierre Saintigny; Charles Mastier; Jérôme Fayette

doi:10.18632/oncotarget.28316

Back

Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Corrigendum 2022 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Andy Karabajakian, Thibaut Garrivier, Carole Crozes, Nicolas Gadot, Jean Yves Blay, F. Bérard, Philippe Céruse, Philippe Zrounba, Pierre Saintigny, Charles Mastier, Jérôme Fayette

Article2025

Therapeutic Targeting of Hypoxia-Inducible Factors in Head and Neck Squamous Cell Carcinoma (HNSCC).

Elizabeth E. Wicks, Shaima Salman, Gregg L. Friedman

Article2025

FER kinase governs invasive growth of head and neck squamous cell carcinoma through dynamic control of growth factor receptor activity

Peter D. Haughton, Lotte Enserink, Sandra Tavares, Wisse E. Haakma, Garik Galustjan, Sjors A. Koppes, Lorenza Casasanta, Else Driehuis, Hans Clevers, Yanchun Zhang, Gaofeng Fan, Stefan M. Willems, Xiaobao Yang, Patrick W.B. Derksen

Article2005

Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

P. Kyzas, Isabella W. Cunha, John P A Ioannidis

Article2018

Head and neck squamous cell carcinoma organoids as a platform for personalized medicine

Else Driehuis, Sigrid Kolders, Lot A. Devriese, Stefan M. Willems, Hans Clevers, Remco de Bree, Emma de Ruiter

Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Abstract

Discussion(0)

Related publications

Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Therapeutic Targeting of Hypoxia-Inducible Factors in Head and Neck Squamous Cell Carcinoma (HNSCC).

FER kinase governs invasive growth of head and neck squamous cell carcinoma through dynamic control of growth factor receptor activity

Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

Head and neck squamous cell carcinoma organoids as a platform for personalized medicine